A randomised phase III trial comparing gemcitabine with surger – only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer - Ueno, H; Kosuge, T; Matsuyama, Y (Br J Cancer, 2009)
et al.